gemcitabine injection solution
apotex inc - gemcitabine (gemcitabine hydrochloride) - solution - 38mg - gemcitabine (gemcitabine hydrochloride) 38mg - antineoplastic agents
gemcitabine sandoz gemcitabine (as hydrochloride) 500 mg/50 ml concentrated solution for infusion vial
sandoz pty ltd - gemcitabine hydrochloride, quantity: 569.5 mg (equivalent: gemcitabine, qty 500 mg) - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; sodium acetate trihydrate - gemcitabine sandoz is indicated for treatment of patients with:. - locally advanced or metastatic non-small cell lung cancer (nsclc). - locally advanced or metastatic adenocarcinoma of the pancreas . - fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated.. - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
gemcitabine sandoz gemcitabine (as hydrochloride) 1000 mg/100 ml concentrated solution for infusion vial
sandoz pty ltd - gemcitabine hydrochloride, quantity: 1139 mg (equivalent: gemcitabine, qty 1000 mg) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; sodium acetate trihydrate - gemcitabine sandoz is indicated for treatment of patients with:. - locally advanced or metastatic non-small cell lung cancer (nsclc). - locally advanced or metastatic adenocarcinoma of the pancreas . - fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated.. - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
gemcitabine sandoz gemcitabine (as hydrochloride) 200 mg/20 ml concentrated solution for infusion vial
sandoz pty ltd - gemcitabine hydrochloride, quantity: 227.8 mg (equivalent: gemcitabine, qty 200 mg) - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; sodium acetate trihydrate - gemcitabine sandoz is indicated for treatment of patients with:. - locally advanced or metastatic non-small cell lung cancer (nsclc). - locally advanced or metastatic adenocarcinoma of the pancreas . - fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated.. - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
gemcitabine thymoorgan1000mg vial as hcl 1000 mg
شركة أدوية الحكمة - hikma pharmaceuticals - gemcitabine as hcl 1000 mg - as hcl 1000 mg
aj-gemcitabine powder for solution
agila jamp canada inc - gemcitabine (gemcitabine hydrochloride) - powder for solution - 200mg - gemcitabine (gemcitabine hydrochloride) 200mg - antineoplastic agents
aj-gemcitabine powder for solution
agila jamp canada inc - gemcitabine (gemcitabine hydrochloride) - powder for solution - 1g - gemcitabine (gemcitabine hydrochloride) 1g - antineoplastic agents
aj-gemcitabine powder for solution
agila jamp canada inc - gemcitabine (gemcitabine hydrochloride) - powder for solution - 2g - gemcitabine (gemcitabine hydrochloride) 2g - antineoplastic agents
gemcitabine 1000mg powder for solution for infusion
1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - gemcitabine - powder for solution for infusion - gemcitabine 1000 mg - antineoplastic agents
gemcitabine 38 mg/ml concentrate for solution for infusion (10ml vial)
pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - gemcitabine - concentrate for solution for infusion - gemcitabine 38 mg/ml - antineoplastic agents